Cargando…
Stratifin accelerates progression of lung adenocarcinoma at an early stage
BACKGROUNDS: Adenocarcinoma in situ (AIS) of the lung has an extremely favorable prognosis. However, early but invasive adenocarcinoma (eIA) sometimes has a fatal outcome. We had previously compared the expression profiles of AIS with those of eIA showing lymph node metastasis or a fatal outcome, an...
Autores principales: | Shiba-Ishii, Aya, Kim, Yunjung, Shiozawa, Toshihiro, Iyama, Shinji, Satomi, Kaishi, Kano, Junko, Sakashita, Shingo, Morishita, Yukio, Noguchi, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518688/ https://www.ncbi.nlm.nih.gov/pubmed/26223682 http://dx.doi.org/10.1186/s12943-015-0414-1 |
Ejemplares similares
-
miR‐3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma
por: Sato, Taiki, et al.
Publicado: (2017) -
Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma
por: Shiozawa, Toshihiro, et al.
Publicado: (2015) -
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
por: Husni, Ryan Edbert, et al.
Publicado: (2019) -
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma
por: Hong, Jeongmin, et al.
Publicado: (2021) -
High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis
por: Nakagawa, Tomoki, et al.
Publicado: (2021)